Keywords: European pharma stocks, Nomura, Growth drivers, Pipelines, Emerging markets

Nomura bearish on European pharmaceuticals

Article | 11 January 2012

With rich valuations driven by cyclical rotation towards all defensives, Nomura pharmaceutical analyst Amit Roy has reinforced his 12-month bearish ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in